Top Pericarditis Companies in Vietnam | Key Players 2026

Top Pericarditis Companies in Vietnam

The following is a data-backed list of the leading Vietnam Pericarditis companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Vietnam Pericarditis Industry, including Novartis (Vietnam) Co., Ltd., Sanofi Vietnam Co., Ltd., and other established names.

List of Pericarditis companies in Vietnam:

1. Novartis (Vietnam) Co., Ltd.

Novartis (Vietnam) Co., Ltd. is a leading pharmaceutical company with strong expertise in inflammatory signalling pathways and cardiovascular care. The company provides targeted therapies that support the effective management of pericardial inflammation and other immune-mediated conditions. Through continuous research, innovation, and patient-focused healthcare solutions, Novartis strengthens Vietnam's pharmaceutical market while improving access to advanced treatments for cardiovascular diseases.

2. Sanofi Vietnam Co., Ltd.

Sanofi Vietnam Co., Ltd. is one of the leading global pharmaceutical companies operating in Vietnam. The company supplies high-efficacy anti-inflammatory medicines and innovative therapeutic solutions for cardiovascular diseases. With a strong commitment to research, healthcare partnerships, and long-term disease management, Sanofi continues to expand access to quality medicines while supporting improved patient outcomes across the Vietnamese healthcare sector.

3. AstraZeneca Vietnam Co., Ltd.

AstraZeneca Vietnam Co., Ltd. is recognized for its leadership in cardiovascular research and innovative pharmaceutical development. The company delivers advanced therapies that support the treatment of inflammatory and cardiovascular diseases while promoting community healthcare initiatives. Through scientific innovation, strategic collaborations, and patient-centered programs, AstraZeneca contributes significantly to improving disease prevention and long-term health outcomes in Vietnam.

4. Pfizer (Vietnam) Ltd.

Pfizer (Vietnam) Ltd. plays a significant role in Vietnam's pharmaceutical industry by supplying proven anti-inflammatory and analgesic medications. The company supports first-line treatment approaches for pericarditis and other inflammatory disorders through its extensive portfolio of innovative medicines. Pfizer also emphasizes research, healthcare partnerships, and improved patient access to high-quality pharmaceutical solutions across the country.

5. Bayer Vietnam Ltd.

Bayer Vietnam Ltd. specializes in advanced cardiovascular and pharmaceutical solutions that support the treatment of inflammatory diseases. The company provides innovative therapies for symptom control and secondary disease management while investing in scientific research and healthcare collaborations. Bayer's commitment to quality and innovation has strengthened its position as a trusted healthcare provider in Vietnam.

6. Merck Vietnam

Merck Vietnam delivers innovative pharmaceutical products and research-driven healthcare solutions across multiple therapeutic areas. The company supports the management of cardiac inflammation through advanced medicines and strong R&D capabilities. By combining scientific expertise with healthcare partnerships, Merck continues to improve treatment standards and expand access to high-quality pharmaceutical solutions in Vietnam.

7. Bristol Myers Squibb (BMS) Vietnam

Bristol Myers Squibb (BMS) Vietnam is a global biopharmaceutical company known for its expertise in immunology and inflammatory diseases. The company develops high-efficacy therapies that help regulate immune-driven pericardial reactions and improve patient outcomes. Through continuous innovation and scientific research, BMS supports the advancement of modern healthcare and specialized treatment options in Vietnam.

8. Eli Lilly (Vietnam) Representative Office

Eli Lilly (Vietnam) Representative Office supports the Vietnamese healthcare market by providing innovative therapeutic solutions for complex inflammatory and cardiovascular conditions. The company focuses on patient-centered treatment approaches and supplies medicines that complement multi-line treatment regimens. Lilly's commitment to research and healthcare innovation continues to strengthen access to advanced pharmaceutical care.

9. Amgen Vietnam

Amgen Vietnam leverages its biotechnology expertise to develop precision therapies for complex inflammatory and immune-mediated diseases. The company emphasizes scientific innovation, biologic medicines, and personalized treatment strategies that address recurrence-prone inflammatory conditions. Through ongoing research and collaboration, Amgen contributes to the advancement of modern healthcare and improved patient outcomes in Vietnam.

10. Binh Dinh Pharmaceutical and Medical Equipment JSC (Bidiphar)

Binh Dinh Pharmaceutical and Medical Equipment JSC (Bidiphar) is one of Vietnam's leading pharmaceutical manufacturers, specializing in drug production and medical products. The company supplies specialized anti-inflammatory medicines and advanced drug delivery solutions through its strong domestic manufacturing capabilities. With decades of experience and a commitment to quality, Bidiphar plays an important role in strengthening Vietnam's pharmaceutical industry.

Frequently Asked Questions About the Market Study (FAQs):